Adverse events2,432

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 2,432

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Phase 1 Symptomatic Placebo	0	24	0
other	Anaemia	Blood and lymphatic system disorders	Phase 1 Symptomatic R10933+R10987 2.4g IV	0	22	0
other	Anaemia	Blood and lymphatic system disorders	Phase 1 Symptomatic R10933+R10987 8.0g IV	0	23	0
other	Anaemia	Blood and lymphatic system disorders	Phase 2 Symptomatic Placebo	0	238	0
other	Anaemia	Blood and lymphatic system disorders	Phase 2 Symptomatic R10933+R10987 2.4g IV	0	236	0
other	Anaemia	Blood and lymphatic system disorders	Phase 2 Symptomatic R10933+R10987 8.0g IV	0	237	0
other	Anaemia	Blood and lymphatic system disorders	Phase 2 Asymptomatic Placebo	0	73	0
other	Anaemia	Blood and lymphatic system disorders	Phase 2 Asymptomatic R10933+R10987 2.4g IV	0	74	0
other	Anaemia	Blood and lymphatic system disorders	Phase 2 Asymptomatic R10933+R10987 8.0g IV	0	75	0
other	Anaemia	Blood and lymphatic system disorders	Phase 3 Age>=18 Placebo	0	2,347	0
other	Anaemia	Blood and lymphatic system disorders	Phase 3 Age>=18 R10933+R10987 1.2g IV	0	2,130	0
other	Anaemia	Blood and lymphatic system disorders	Phase 3 Age>=18 R10933+R10987 2.4g IV	7	3,157	7
other	Anaemia	Blood and lymphatic system disorders	Phase 3 Age>=18 R10933+R10987 8.0g IV	1	1,012	1
other	Anaemia	Blood and lymphatic system disorders	Phase 3 Age<18 Placebo	0	2	0
other	Anaemia	Blood and lymphatic system disorders	Phase 3 Age<18 R10933+R10987 1.2g IV	0	129	0
other	Anaemia	Blood and lymphatic system disorders	Phase 3 Age<18 R10933+R10987 2.4g IV	1	71	1
other	Anaemia	Blood and lymphatic system disorders	Phase 3 Pregnant Placebo	0	2	0
other	Anaemia	Blood and lymphatic system disorders	Phase 3 Pregnant R10933+R10987 1.2g IV	3	43	3
other	Anaemia	Blood and lymphatic system disorders	Phase 3 Pregnant R10933+R10987 2.4g IV	0	35	0
other	Gestational diabetes	Pregnancy, puerperium and perinatal conditions	Phase 1 Symptomatic Placebo	0	24	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04425629/events

API reference For AI assistants

Adverse events2,432

Sources 3

Read this list from software.